246 related articles for article (PubMed ID: 10148086)
21. Innovations in pulse generators and lead systems: balancing complexity with clinical benefit and long-term results.
Saksena S; Krol RB; Kaushik RR
Am Heart J; 1994 Apr; 127(4 Pt 2):1010-21. PubMed ID: 8160574
[TBL] [Abstract][Full Text] [Related]
22. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation.
Yee R; Klein GJ; Leitch JW; Guiraudon GM; Guiraudon CM; Jones DL; Norris C
Circulation; 1992 Jan; 85(1):196-204. PubMed ID: 1728450
[TBL] [Abstract][Full Text] [Related]
23. The role of cardioversion therapy in patients with implanted cardioverter defibrillators.
Nathan AW
Am Heart J; 1994 Apr; 127(4 Pt 2):1046-51. PubMed ID: 8160579
[TBL] [Abstract][Full Text] [Related]
24. Electrical therapy of arrhythmias.
Seger JJ; Griffin JC
Cardiol Clin; 1985 Nov; 3(4):617-22. PubMed ID: 3910241
[TBL] [Abstract][Full Text] [Related]
25. Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator.
Tjong FVY; Brouwer TF; Kooiman KM; Smeding L; Koop B; Soltis B; Shuros A; Wilde AAM; Burke M; Knops RE
J Am Coll Cardiol; 2016 Apr; 67(15):1865-1866. PubMed ID: 27012782
[No Abstract] [Full Text] [Related]
26. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
[TBL] [Abstract][Full Text] [Related]
27. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
Groh WJ; Foreman LD; Zipes DP
Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
[TBL] [Abstract][Full Text] [Related]
28. Twenty-Seven Years Experience With Transvenous Pacemaker Implantation in Children Weighing <10 kg.
Konta L; Chubb MH; Bostock J; Rogers J; Rosenthal E
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003422. PubMed ID: 26857908
[TBL] [Abstract][Full Text] [Related]
29. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
Klein HU; Goldenberg I; Moss AJ
Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
[TBL] [Abstract][Full Text] [Related]
30. A Shocking End to the Defibrillator as We Know It: Unmet Needs and the Case for a Stand-Alone Device that Uses Pacing Only to Treat the Risk of Life-Threatening Arrhythmias.
Gimbel JR
Pacing Clin Electrophysiol; 2015 Jun; 38(6):655-8. PubMed ID: 25640284
[TBL] [Abstract][Full Text] [Related]
31. Virtual clinics for follow-up of pacemakers and implantable cardioverter defibrillators in children.
Spentzou G; Mayne K; Fulton H; McLeod K
Cardiol Young; 2019 Oct; 29(10):1243-1247. PubMed ID: 32167039
[TBL] [Abstract][Full Text] [Related]
32. Pacing induced ventricular fibrillation in internal cardioverter defibrillator patients: a new form of proarrhythmia.
Vlay LC; Vlay SC
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):132-3. PubMed ID: 9121960
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the Extravascular Implantable Defibrillator: Feasibility of Substernal Ventricular Pacing.
Brouwer TF; Smeding L; Berger WR; Driessen AHG; DE Groot JR; Wilde AAM; Knops RE
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):674-676. PubMed ID: 28245342
[TBL] [Abstract][Full Text] [Related]
34. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.
Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Kelso D; Mitchell R
Circulation; 1993 Jun; 87(6):1889-96. PubMed ID: 8504501
[TBL] [Abstract][Full Text] [Related]
35. Potential proarrhythmic effects of implantable cardioverter-defibrillators.
Duru F; Candinas R
Clin Cardiol; 1999 Feb; 22(2):139-46. PubMed ID: 10068856
[TBL] [Abstract][Full Text] [Related]
36. The current status of the implantable cardioverter defibrillator.
Gillis AM
Annu Rev Med; 1996; 47():85-93. PubMed ID: 8712805
[TBL] [Abstract][Full Text] [Related]
37. Implantable cardiac defibrillators.
Peters RW; Gold MR
Med Clin North Am; 2001 Mar; 85(2):343-67, xi. PubMed ID: 11233952
[TBL] [Abstract][Full Text] [Related]
38. Inappropriate discharge of an implantable cardioverter defibrillator during atrial flutter and intermittent ventricular antibradycardia pacing.
Peters W; Kowallik P; Wittenberg G; Scholl C; Meesmann M
J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1167-74. PubMed ID: 9363821
[TBL] [Abstract][Full Text] [Related]
39. External cardioversion of atrial fibrillation and flutter in patients with cardiac implantable electrical devices.
Elgaard AF; Dinesen PT; Riahi S; Hansen J; Lundbye-Christensen S; Thøgersen AM; Larsen JM
Pacing Clin Electrophysiol; 2023 Feb; 46(2):108-113. PubMed ID: 36333921
[TBL] [Abstract][Full Text] [Related]
40. Pacing threshold increase in nonthoracotomy implantable defibrillator leads: implications for battery longevity and margin of safety.
Epstein AE; Plumb VJ; Kirk KA; Kay GN
J Interv Card Electrophysiol; 1997 Sep; 1(2):131-4. PubMed ID: 9869961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
